PharmaBlock Sciences (Nanjing), Inc. (300725.SZ)
CNY 35.85
(0.25%)
CNY 35.85
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.72 Billion | 1.59 Billion | 1.2 Billion | 1.02 Billion | 662.23 Million | 478.25 Million |
| Cost of Revenue | 1.02 Billion | 869.49 Million | 623.34 Million | 554.16 Million | 320.57 Million | 201.74 Million |
| Gross Profit | 695.45 Million | 725.2 Million | 578.28 Million | 468.06 Million | 341.65 Million | 276.51 Million |
| Operating Expenses | 548.93 Million | 428.69 Million | 296.93 Million | 249.12 Million | 174.79 Million | 132.31 Million |
| Selling, General and Administrative Expenses | 118.22 Million | 112.89 Million | 90.84 Million | 97.64 Million | 49.83 Million | 37.13 Million |
| Research and Development Expenses | 169.17 Million | 168.32 Million | 114.02 Million | 90.92 Million | 69.22 Million | 44.35 Million |
| Other Expenses | 90.03 Million | 147.48 Million | 92.06 Million | 60.54 Million | 55.74 Million | 11.42 Million |
| Cost and Expenses | 1.54 Billion | 1.29 Billion | 920.27 Million | 803.29 Million | 495.37 Million | 334.05 Million |
| Operating Income | 259.22 Million | 296.7 Million | 492.95 Million | 194.12 Million | 163.53 Million | 142.97 Million |
| Interest Expense | 68.19 Million | 45.72 Million | 9.18 Million | 630.51 Thousand | 3.26 Million | 1 Million |
| Income Tax Expense | 24.01 Million | -2.62 Million | 4 Million | 20.3 Million | 20.27 Million | 19.9 Million |
| Earnings before Tax | 221.37 Million | 323.26 Million | 507.76 Million | 204.5 Million | 172.35 Million | 154.4 Million |
| Net Income | 197.36 Million | 314.22 Million | 486.55 Million | 184.2 Million | 152.06 Million | 133.36 Million |
| Earnings Per Share Basic | 0.99 | 1.57 | 2.45 | 0.99 | 0.82 | 0.72 |
| Earnings Per Share Diluted | 0.98 | 1.57 | 2.44 | 0.75 | 0.82 | 0.72 |
| Weighted Average Shares Outstanding | 199.35 Million | 199.66 Million | 198.99 Million | 186.59 Million | 185.9 Million | 185.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 201.38 Million | 200.14 Million | 199.4 Million | 244.35 Million | 185.9 Million | 186.42 Million |
| Gross Margin | 0.40 | 0.45 | 0.48 | 0.46 | 0.52 | 0.58 |
| EBIT Margin | 0.22 | 0.29 | 0.48 | 0.23 | 0.30 | 0.37 |
| Profit Margin | 0.11 | 0.20 | 0.40 | 0.18 | 0.23 | 0.28 |
| EBITDA | 380.8 Million | 471.52 Million | 581.73 Million | 229.6 Million | 196.73 Million | 180.95 Million |
| Earnings Before Tax Margin | 0.15 | 0.19 | 0.41 | 0.19 | 0.25 | 0.30 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 376.38 Million | 361.61 Million | 372.35 Million | 1.7 Billion | 424.93 Million | 447.4 Million |
| Cost of Revenue | 239.45 Million | 233.64 Million | 216.31 Million | 1.02 Billion | 263.5 Million | 262.31 Million |
| Gross Profit | 136.92 Million | 127.96 Million | 156.04 Million | 676.82 Million | 161.42 Million | 185.08 Million |
| Operating Expenses | 91.04 Million | 96.07 Million | 102.35 Million | 417.6 Million | 110.42 Million | 104.58 Million |
| Selling, General and Administrative Expenses | 62.35 Million | 52.92 Million | 60.09 Million | - | 60.19 Million | 132.33 Million |
| Research and Development Expenses | 26.05 Million | 25.37 Million | 34.51 Million | - | 33.58 Million | 40.06 Million |
| Other Expenses | -2.63 Million | -17.77 Million | -7.74 Million | -23.12 Million | -16.64 Million | 35.14 Million |
| Cost and Expenses | 330.5 Million | 329.71 Million | 318.66 Million | 1.44 Billion | 373.93 Million | 366.9 Million |
| Operating Income | 45.88 Million | 31.89 Million | 53.68 Million | 259.22 Million | 51 Million | 47.17 Million |
| Interest Expense | 16.17 Million | 15.04 Million | 15.4 Million | 66.09 Million | 16.74 Million | 17.12 Million |
| Income Tax Expense | 4.16 Million | 5.91 Million | 6.11 Million | 24.01 Million | 7.92 Million | 9.1 Million |
| Earnings before Tax | 37.45 Million | 55.12 Million | 55.6 Million | 223.09 Million | 51.93 Million | 49.25 Million |
| Net Income | 33.09 Million | 49.2 Million | 49.48 Million | 197.36 Million | 43.31 Million | 40.15 Million |
| Earnings Per Share Basic | 0.17 | 0.25 | 0.25 | - | 0.22 | 0.20 |
| Earnings Per Share Diluted | 0.17 | 0.25 | 0.24 | - | 0.21 | 0.20 |
| Weighted Average Shares Outstanding | 198.91 Million | 198.82 Million | 199.66 Million | 199.35 Million | 199.15 Million | 199.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.63 Million | 198.82 Million | 206.18 Million | 201.38 Million | 204.21 Million | 200.57 Million |
| Gross Margin | 0.36 | 0.35 | 0.42 | 0.40 | 0.38 | 0.41 |
| EBIT Margin | 0.14 | 0.18 | 0.19 | - | 0.19 | 0.26 |
| Profit Margin | 0.09 | 0.14 | 0.13 | 0.12 | 0.10 | 0.09 |
| EBITDA | 53.62 Million | 66.54 Million | 69.53 Million | - | 82.58 Million | 118.41 Million |
| Earnings Before Tax Margin | 0.12 | 0.09 | 0.14 | 0.15 | 0.12 | 0.11 |
NCRBF
4166
NATR
1766
6347
HMU